Clinical trials
Phase 2/3 Post-Acute COVID-19 Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amsterdam UMC, location VUmc | 1 |
| Cellular Sciences, inc. | 1 |
| HealthBio, Inc. | 1 |
| Hellenic Institute for the Study of Sepsis | 1 |
| Laurent Pharmaceuticals Inc. | 1 |
| Medical University of South Carolina | 1 |
| Resverlogix Corp | 1 |
| Swedish Herbal Institute AB | 1 |
| University Health Network, Toronto | 1 |
| University of Alberta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Post-Acute COVID-19 Syndrome | 12 |
| COVID-19 | 6 |
| Anosmia | 1 |
| Anxiety Disorders | 1 |
| Cognition Disorders | 1 |
| Fatigue | 1 |
| Headache | 1 |
| Olfaction Disorders | 1 |
| Pulmonary Fibrosis | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.